| Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... Cancer discovery 7 (2), 188-201, 2017 | 1165 | 2017 |
| Tumour-intrinsic resistance to immune checkpoint blockade A Kalbasi, A Ribas Nature Reviews Immunology 20 (1), 25-39, 2020 | 1000 | 2020 |
| Radiation and immunotherapy: a synergistic combination A Kalbasi, CH June, N Haas, N Vapiwala The Journal of clinical investigation 123 (7), 2756-2763, 2013 | 325 | 2013 |
| Conserved interferon-γ signaling drives clinical response to immune checkpoint blockade therapy in melanoma CS Grasso, J Tsoi, M Onyshchenko, G Abril-Rodriguez, ... Cancer cell 38 (4), 500-515. e3, 2020 | 265 | 2020 |
| Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma A Kalbasi, C Komar, GM Tooker, M Liu, JW Lee, WL Gladney, E Ben-Josef, ... Clinical Cancer Research 23 (1), 137-148, 2017 | 265 | 2017 |
| SD-101 in combination with pembrolizumab in advanced melanoma: results of a phase Ib, multicenter study A Ribas, T Medina, S Kummar, A Amin, A Kalbasi, JJ Drabick, M Barve, ... Cancer discovery 8 (10), 1250-1257, 2018 | 264 | 2018 |
| Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov. 2017; 7: 188–201. doi: 10.1158/2159-8290 DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... CD-16-1223.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 251 | |
| Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer A Kalbasi, J Li, AT Berman, S Swisher-McClure, M Smaldone, RG Uzzo, ... JAMA oncology 1 (7), 897-906, 2015 | 178 | 2015 |
| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 167 | 2021 |
| Overcoming genetically based resistance mechanisms to PD-1 blockade DY Torrejon, G Abril-Rodriguez, AS Champhekar, J Tsoi, KM Campbell, ... Cancer discovery 10 (8), 1140-1157, 2020 | 106 | 2020 |
| PAK4 inhibition improves PD-1 blockade immunotherapy G Abril-Rodriguez, DY Torrejon, W Liu, JM Zaretsky, TS Nowicki, J Tsoi, ... Nature Cancer 1 (1), 46-58, 2020 | 104 | 2020 |
| Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma A Kalbasi, M Tariveranmoshabad, K Hakimi, S Kremer, KM Campbell, ... Science translational medicine 12 (565), eabb0152, 2020 | 90 | 2020 |
| A pilot trial of the combination of transgenic NY-ESO-1–reactive adoptive cellular therapy with dendritic cell vaccination with or without ipilimumab TS Nowicki, B Berent-Maoz, G Cheung-Lau, RR Huang, X Wang, J Tsoi, ... Clinical Cancer Research 25 (7), 2096-2108, 2019 | 81 | 2019 |
| A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases C Xie, HJ Kim, JG Haw, A Kalbasi, BK Gardner, G Li, J Rao, D Chia, ... Journal of translational medicine 9, 1-11, 2011 | 79 | 2011 |
| Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high‐risk pathologic features A Kalbasi, S Swisher‐McClure, N Mitra, R Sunderland, MC Smaldone, ... Cancer 120 (19), 3089-3096, 2014 | 76 | 2014 |
| A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma A Kalbasi, M Kamrava, FI Chu, D Telesca, R Van Dams, Y Yang, D Ruan, ... Clinical Cancer Research 26 (8), 1829-1836, 2020 | 72 | 2020 |
| Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles KM Campbell, G Steiner, DK Wells, A Ribas, A Kalbasi BioRxiv, 2020.03. 30.016931, 2020 | 50 | 2020 |
| Potentiating adoptive cell therapy using synthetic IL-9 receptors A Kalbasi, M Siurala, LL Su, M Tariveranmoshabad, LK Picton, ... Nature 607 (7918), 360-365, 2022 | 45 | 2022 |
| Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs Y Gao, A Kalbasi, W Hsu, D Ruan, J Fu, J Shao, M Cao, C Wang, ... Physics in Medicine & Biology 65 (17), 175006, 2020 | 45 | 2020 |
| Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas JD Pennington, FC Eilber, FR Eilber, AS Singh, JP Reed, B Chmielowski, ... American journal of clinical oncology 41 (12), 1154-1161, 2018 | 38 | 2018 |
